# A Study of an Eczema Spot Treatment in Providing Eczema Symptoms Relief and Lasting Itch Relief to Affected Skin Area

> **NCT05226143** · NA · COMPLETED · sponsor: **Johnson & Johnson Consumer Inc. (J&JCI)** · enrollment: 37 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **OTHER:** Gel Cream

## Key facts

- **NCT ID:** NCT05226143
- **Lead sponsor:** Johnson & Johnson Consumer Inc. (J&JCI)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-21
- **Primary completion:** 2022-03-09
- **Final completion:** 2022-03-09
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2022-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05226143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05226143, "A Study of an Eczema Spot Treatment in Providing Eczema Symptoms Relief and Lasting Itch Relief to Affected Skin Area". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05226143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*